310.67
price up icon20.88%   53.67
after-market Handel nachbörslich: 312.00 1.33 +0.43%
loading
Schlusskurs vom Vortag:
$257.00
Offen:
$293.03
24-Stunden-Volumen:
3.21M
Relative Volume:
3.85
Marktkapitalisierung:
$18.08B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$420.90M
KGV:
53.20
EPS:
5.84
Netto-Cashflow:
$218.20M
1W Leistung:
+20.88%
1M Leistung:
+17.36%
6M Leistung:
+15.92%
1J Leistung:
+75.00%
1-Tages-Spanne:
Value
$293.03
$312.16
1-Wochen-Bereich:
Value
$252.88
$312.16
52-Wochen-Spanne:
Value
$160.19
$312.16

Insulet Corporation Stock (PODD) Company Profile

Name
Firmenname
Insulet Corporation
Name
Telefon
978-600-7000
Name
Adresse
100 NAGOG PARK, ACTON, MA
Name
Mitarbeiter
3,900
Name
Twitter
@insulet_uk
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PODD's Discussions on Twitter

Vergleichen Sie PODD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
PODD
Insulet Corporation
310.67 18.08B 1.98B 420.90M 218.20M 5.84
Medical Devices icon
ABT
Abbott Laboratories
133.24 231.09B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.86 155.24B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
380.92 144.54B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
83.48 108.82B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
73.68 44.31B 5.54B 4.18B 623.10M 7.00

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-29 Herabstufung Wolfe Research Outperform → Peer Perform
2025-03-06 Eingeleitet RBC Capital Mkts Outperform
2024-11-06 Eingeleitet Bernstein Outperform
2024-05-30 Eingeleitet Redburn Atlantic Buy
2024-05-07 Hochstufung Wolfe Research Peer Perform → Outperform
2023-12-21 Hochstufung Robert W. Baird Neutral → Outperform
2023-12-04 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-10-02 Hochstufung Jefferies Hold → Buy
2023-08-21 Hochstufung Citigroup Neutral → Buy
2023-08-21 Herabstufung Robert W. Baird Outperform → Neutral
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-01-26 Eingeleitet Wolfe Research Peer Perform
2022-11-04 Hochstufung Piper Sandler Neutral → Overweight
2022-10-18 Eingeleitet Barclays Equal Weight
2022-10-12 Eingeleitet Jefferies Hold
2022-07-11 Herabstufung Citigroup Buy → Neutral
2022-03-02 Fortgesetzt BofA Securities Buy
2022-02-03 Hochstufung BTIG Research Neutral → Buy
2022-02-02 Hochstufung UBS Neutral → Buy
2022-01-31 Hochstufung Oppenheimer Perform → Outperform
2021-07-21 Fortgesetzt Cowen Outperform
2021-05-25 Eingeleitet Barclays Overweight
2021-04-01 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-03-19 Hochstufung Canaccord Genuity Hold → Buy
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2020-12-16 Herabstufung Citigroup Buy → Neutral
2020-07-28 Eingeleitet Wells Fargo Overweight
2020-04-24 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-04-03 Eingeleitet BofA/Merrill Neutral
2020-03-31 Herabstufung Berenberg Buy → Hold
2020-03-05 Eingeleitet Citigroup Buy
2019-12-10 Eingeleitet CFRA Sell
2019-10-23 Eingeleitet Stifel Hold
2019-10-18 Herabstufung Canaccord Genuity Buy → Hold
2019-10-14 Herabstufung BTIG Research Buy → Neutral
2019-10-04 Herabstufung UBS Buy → Neutral
2019-10-03 Herabstufung Guggenheim Buy → Neutral
2019-08-06 Hochstufung JP Morgan Neutral → Overweight
2019-06-10 Herabstufung Northland Capital Outperform → Market Perform
2019-05-06 Hochstufung BTIG Research Neutral → Buy
2018-04-20 Eingeleitet Berenberg Buy
2018-02-22 Bestätigt Barclays Overweight
2018-01-08 Hochstufung Raymond James Mkt Perform → Outperform
2017-11-03 Hochstufung Canaccord Genuity Hold → Buy
2017-09-15 Eingeleitet Barclays Overweight
Alle ansehen

Insulet Corporation Aktie (PODD) Neueste Nachrichten

pulisher
08:29 AM

Insulet Corporation (NASDAQ:PODD) Q1 2025 Earnings Call Transcript - Insider Monkey

08:29 AM
pulisher
12:58 PM

Insulet (PODD) Sees Price Target Boost Amid Strong Sales Performance | PODD Stock News - GuruFocus

12:58 PM
pulisher
May 09, 2025

BTIG raises Insulet stock price target to $330, maintains Buy rating - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Insulet’s Earnings Call Reveals Strong Growth and Expansion - TipRanks

May 09, 2025
pulisher
May 09, 2025

Piper Sandler maintains Overweight rating on Insulet stock By Investing.com - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Insulet Seeks $30M In Atty Fees, Costs After Trade Secret Win - Law360

May 09, 2025
pulisher
May 09, 2025

U.S. Indexes Ended Friday Mixed As Insulet Led, Affirm Holdings Lagged - Barron's

May 09, 2025
pulisher
May 09, 2025

New Insulet CEO Ashley McEvoy sets priorities - MedTech Dive

May 09, 2025
pulisher
May 09, 2025

Sector Update: Health Care - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Canaccord raises Insulet stock target to $331, maintains buy rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

Piper Sandler maintains Overweight rating on Insulet stock - Investing.com

May 09, 2025
pulisher
May 09, 2025

Why Insulet (PODD) Stock Is Trading Up Today - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Insulet Stock Soars to Lead S&P 500 Gainers Friday - Investopedia

May 09, 2025
pulisher
May 09, 2025

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Tesla, Insulet Surge Among Market Cap Stock Movers on Friday By Investing.com - Investing.com South Africa

May 09, 2025
pulisher
May 09, 2025

Tesla, Insulet Surge Among Market Cap Stock Movers on Friday - Investing.com Australia

May 09, 2025
pulisher
May 09, 2025

Insulet (PODD) Price Target Raised by Oppenheimer Analyst | PODD Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025 - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More - Investopedia

May 09, 2025
pulisher
May 09, 2025

Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad - Benzinga

May 09, 2025
pulisher
May 09, 2025

Trade Desk, Insulet Surge in Friday’s Market Cap Stock Movers By Investing.com - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Trade Desk, Insulet Surge in Friday’s Market Cap Stock Movers - Investing.com Australia

May 09, 2025
pulisher
May 09, 2025

Insulet Stock Is the Top S&P 500 Performer Today. Here’s Why. - MSN

May 09, 2025
pulisher
May 09, 2025

Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

Piper Sandler on Insulet Corporation (PODD): 'Strong Update Across the Board' - StreetInsider

May 09, 2025
pulisher
May 09, 2025

Canaccord raises Insulet stock target to $331, maintains buy rating By Investing.com - Investing.com India

May 09, 2025
pulisher
May 09, 2025

BTIG Boosts Price Target for Insulet (PODD) After Strong Q1 Results | PODD Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Insulet Corporation Exceeds Q1 CY2025 Revenue ExpectationsNews and Statistics - IndexBox

May 09, 2025
pulisher
May 09, 2025

Insulet Corporation (PODD) PT Raised to $331 at Canaccord Genuity - StreetInsider

May 09, 2025
pulisher
May 09, 2025

Insulet Corporation (PODD) PT Raised to $330 at BTIG - StreetInsider

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Insulet beats Q1 2025 forecasts, stock surges By Investing.com - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Insulet Corp (PODD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Insulet Corporation Reports Strong Q1 2025 Growth - TipRanks

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: Insulet beats Q1 2025 forecasts, stock surges - Investing.com Australia

May 08, 2025
pulisher
May 08, 2025

Insulet requests $30 million in attorneys fees after EOFlow trade secret injunction - MLex

May 08, 2025
pulisher
May 08, 2025

Insulet’s (NASDAQ:PODD) Q1: Strong Sales, Stock Soars - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Insulet: Q1 Earnings Snapshot - MySA

May 08, 2025
pulisher
May 08, 2025

Insulet's Strong Profit And Innovation Propel Shares Higher - Finimize

May 08, 2025
pulisher
May 08, 2025

Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Insulet Q4 2024 slides: revenue tops $2.1B, margins expand as Type 2 diabetes push begins - Investing.com

May 08, 2025
pulisher
May 08, 2025

Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Insulet Corp (PODD) Q1 2025 Earnings: Revenue Surges to $569M, Beating Estimates, EPS Falls Short at $0.50 - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Insulet Jumps After Beating Quarterly Forecasts, Raising 2025 Expectations - MSN

May 08, 2025
pulisher
May 08, 2025

Insulet earnings beat by $0.23, revenue topped estimates By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Insulet beats quarterly profit estimates on insulin pump demand - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Insulet earnings beat by $0.23, revenue topped estimates - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Insulet Q1 Earnings Fall, Revenue Rises - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Insulet (PODD) Reports Strong Q1 Revenue Beating Estimates | PODD Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1) - Business Wire

May 08, 2025
pulisher
May 07, 2025

Insulet Pursues EOFlow's Finances After $60M Ruling - Law360

May 07, 2025

Finanzdaten der Insulet Corporation-Aktie (PODD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$95.21
price up icon 0.11%
medical_devices STE
$226.43
price up icon 0.25%
medical_devices PHG
$24.54
price up icon 1.95%
$84.67
price down icon 0.79%
$69.87
price down icon 0.89%
medical_devices EW
$73.68
price down icon 1.27%
Kapitalisierung:     |  Volumen (24h):